Cardiovascular risk in the peritoneal dialysis patient (Q37766750)

22 August 2017

1 reference

title

Cardiovascular risk in the peritoneal dialysis patient (English)

1 reference

22 August 2017

0 references

1 reference

1 reference

1 reference

Raymond T Krediet

1

1 reference

PubMed ID

20567248

22 August 2017

Olga Balafa

series ordinal

2

1 reference

PubMed ID

20567248

22 August 2017

language of work or name

English

0 references

publication date

22 June 2010

1 reference

Nature Reviews Nephrology

22 August 2017

1 reference

22 August 2017

6

1 reference

22 August 2017

8

1 reference

22 August 2017

451-460

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2010.68

22 August 2017

0 references

cites work

Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Cardiovascular and noncardiovascular mortality among patients starting dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Blood pressure and mortality risk on peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Effect of fluid and sodium removal on mortality in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Long-term evolution of cardiomyopathy in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Aortic PWV in chronic kidney disease: a CRIC ancillary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Arterial pulse wave velocity and peritoneal transport characteristics independently predict hospitalization in Chinese peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients--absence of evidence or evidence of absence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Body size and outcomes on peritoneal dialysis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Stimulation of the acute-phase response in simian virus 40-hepatocyte cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Soluble adhesion molecules in end-stage renal disease: a predictor of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Is malnutrition an independent predictor of mortality in peritoneal dialysis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Reassessment of albumin as a nutritional marker in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Malnutrition-inflammation score independently determined cardiovascular and infection risk in peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Elevated plasma F2-isoprostanes in patients on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Preserved residual renal function is associated with lower oxidative stress in peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Cardiovascular disease in dialysis patients: do some antihypertensive drugs have specific antioxidant effects or is it just blood pressure reduction? Does antioxidant treatment reduce the risk for cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Fetuin-A protects against atherosclerotic calcification in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Vitamin D in the prevention and treatment of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Association of activated vitamin D treatment and mortality in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Homocysteine in uraemia--a puzzling and conflicting story

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

A broad-based metabolic approach to study VLDL apoB100 metabolism in patients with ESRD and patients treated with peritoneal dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

The importance of residual kidney function for patients on dialysis: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Residual renal function and mortality risk in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Predictors of survival in anuric peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Vitamin D levels and patient outcome in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

UK Renal Registry 11th Annual Report (December 2008): Chapter 11 Blood pressure profile of prevalent patients receiving dialysis in the UK in 2007: national and centre-specific analyses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Mortality and technique failure in patients starting chronic peritoneal dialysis: Results of the Netherlands Cooperative Study on the Adequacy of Dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Inflammation, Residual Kidney Function, and Cardiac Hypertrophy Are Interrelated and Combine Adversely to Enhance Mortality and Cardiovascular Death Risk of Peritoneal Dialysis Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Arterial stiffening and vascular calcifications in end-stage renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

The study of aortic stiffness in different hypertension subtypes in dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Association between Body Mass Index and Mortality Is Similar in the Hemodialysis Population and the General Population at High Age and Equal Duration of Follow-Up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Is obesity associated with a survival advantage in patients starting peritoneal dialysis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

C-reactive protein and cardiovascular disease in peritoneal dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

31 March 2020

12 December 2020

Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Serial monitoring of nutritional status in Chinese peritoneal dialysis patients by Subjective Global Assessment and comprehensive Malnutrition Inflammation Score

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Oxidative stress is progressively enhanced with advancing stages of CKD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Impact of residual renal function on plasma levels of advanced oxidation protein products and pentosidine in peritoneal dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Carotid atherosclerosis is associated with enhanced beta-chemokine levels in patients on continuous ambulatory peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Cardiac Valve Calcification as an Important Predictor for All-Cause Mortality and Cardiovascular Mortality in Long-Term Peritoneal Dialysis Patients: A Prospective Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Association of serum fetuin-A levels with mortality in dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Vitamin D levels and early mortality among incident hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Does TREAT give the boot to ESAs in the treatment of CKD anemia?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

The normal hematocrit study--follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Intraperitoneal infusion of dialysate: a possible cause of increased plasma atrial natriuretic peptide levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Dry body weight: water and sodium removal targets in PD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.68

Blood pressure control and left ventricular hypertrophy in long-term CAPD and hemodialysis patients: a cross-sectional study.

31 March 2020

1 reference

12 December 2020

Acute effects of peritoneal dialysis on hemodynamics.

1 reference

12 December 2020

Continuous ambulatory peritoneal dialysis (CAPD) in patients with diabetic nephropathy

1 reference

12 December 2020

B-type natriuretic peptide and amino-terminal atrial natriuretic peptide predict survival in peritoneal dialysis.

1 reference

12 December 2020

Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis

1 reference

12 December 2020

Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy

1 reference

12 December 2020

The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambulatory peritoneal dialysis.

1 reference

12 December 2020

Serum advanced glycosylation end-products in patients on hemodialysis and CAPD

1 reference

12 December 2020

Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance).

1 reference

12 December 2020

Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients

1 reference

12 December 2020

Effective homocysteine-lowering vitamin B treatment in peritoneal dialysis patients

1 reference

12 December 2020

Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study.

1 reference

12 December 2020

Large body mass index does not predict short-term survival in peritoneal dialysis patients.

1 reference

12 December 2020

Clinical epidemiology of cardiovascular disease in chronic renal disease

1 reference

12 December 2020

Epidemiology of cardiovascular risk in patients with chronic kidney disease.

1 reference

12 December 2020

Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.

1 reference

12 December 2020

Anaemia and inflammation: what are the implications for the nephrologist?

1 reference

12 December 2020

Reduced 1,2-dicarbonyl compounds in bicarbonate/lactate-buffered peritoneal dialysis (PD) fluids and PD fluids based on glucose polymers or amino acids

1 reference

12 December 2020

Is obesity a favorable prognostic factor in peritoneal dialysis patients?

1 reference

12 December 2020

Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients

1 reference

12 December 2020

Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study.

1 reference

12 December 2020

Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure

1 reference

12 December 2020

Insulin resistance and glucose homeostasis in peritoneal dialysis.

1 reference

12 December 2020

A pyruvate-buffered dialysis fluid induces less peritoneal angiogenesis and fibrosis than a conventional solution.

1 reference

12 December 2020

Comparison of changes in pulse wave velocity in patients on continuous ambulatory peritoneal dialysis and hemodialysis one year after introduction of dialysis therapy

1 reference

12 December 2020

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

1 reference

12 December 2020

Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial

1 reference

12 December 2020

1995 update of the working group reports on chronic renal failure and renovascular hypertension. National High Blood Pressure Education Program Working Group

1 reference

12 December 2020

Current and former smoking increases mortality in patients on peritoneal dialysis

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2010.68

1 reference

22 August 2017

1 reference

PubMed ID

20567248